Data and Analytics

Watch Truveris’ exclusive Human Resources round table, originally recorded on June 8th, 2022.

Plan sponsors are looking for new ways to contain specialty costs. How should they evaluate new copay assistance strategies?

Truveris covers exactly how leading employer groups and their brokers are implementing copay maximizers and accumulators.

As pharmacy costs increase, what are strategies plan sponsors can take to control specialty pharmacy spend?

With so much importance placed on the launch of a new drug, how should pharma brands ensure a successful launch?  

How are copay maximizers and alternative funding impacting plans – and members? Watch our on-demand webinar to learn more.

Truveris announces the launch of oneRx, the only drug price transparency solution that helps members navigate their pharmacy benefits.

After you procure a strong PBM contract, make sure your members are engaging with the plan productively.

See how Truveris has helped employers of all sizes procure their pharmacy benefits.

By framing your pharmacy benefits strategy around these three pillars, you’ll construct a more cost-effective, accessible pharmacy program.

With Delta and Omicron, the COVID-19 pandemic carries on. How are these variants impacting pharma brands?

Many brands experience a drop in claims during January. What strategies successfully drive adherence during the beginning of the year?

Truveris’ Life Sciences data science team conducted a deep-dive analysis to assess the impact of COVID-19 on prescribing and claim volume throughout an 18-month span.